Sanofi-Novavax licensing deal looks to boost post-pandemic vaccine sales
Agreement worth up to $1.2bn includes plan for combined flu and Covid-19 shots
Full Article
Sanofi-Novavax licensing deal looks to boost post-pandemic vaccine sales
FT.com
0 shares
1 views